Advertisement

Topics

20182023 United States Capecitabine Market Report Status and Outlook [Report Updated: 13032018] Prices from USD $3360

21:21 EDT 12 Jul 2018 | BioPortfolio Report Blog

In 2017, the Capecitabine market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.


In United States market, the top players include

Roche

Teva

Mylan

Hikma

Hengrui Medicine

Cipla

Reliance Group

Hetero


Split by product types/category, covering

500 mg

150 mg


Split by applications/end use industries, covers

Breast Cancer

Colorectal Cancer

Stomach Cancer

Original Article: 20182023 United States Capecitabine Market Report Status and Outlook [Report Updated: 13032018] Prices from USD $3360

NEXT ARTICLE

More From BioPortfolio on "20182023 United States Capecitabine Market Report Status and Outlook [Report Updated: 13032018] Prices from USD $3360"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...